NF-κB RelA opposes epidermal proliferation driven by TNFR1 and JNK

Genes and Development

Volumn 18, Issue 1, 2004, Pages 17-22

  Zhang, Jennifer Y ^a   Green, Cheryl L ^a   Tao, Shiying ^a   Khavari, Paul A ^a  

^a NONE

Author keywords

Differentiation; Epidermis; NF B; Proliferation

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR RECEPTOR 1; DNA BINDING PROTEIN; LEUKOCYTE ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEATH; ENZYME ACTIVATION; EPIDERMIS; EPIDERMIS CELL; HOMEOSTASIS; HUMAN; HUMAN TISSUE; HYPERPLASIA; INFLAMMATION; LETHAL MUTANT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; CYTOLOGY; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; KERATINOCYTE; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; PRENATAL DEVELOPMENT; SKIN; WESTERN BLOTTING;

ANIMALIA;

ANIMALS; ANTIGENS, CD; BLOTTING, WESTERN; CELL DIVISION; DNA-BINDING PROTEINS; EMBRYO; EPIDERMIS; KERATINOCYTES; MICE; MICE, SCID; NF-KAPPA B; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SKIN; TRANSCRIPTION FACTOR RELA;

EID: 0346497823     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1160904     Document Type: Article

References (37)

1. Aggarwal, B.B. 2000. Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-κB. Ann. Rheum. Dis. 59 Suppl 1: i6-i16.
2. Alcamo, E., Mizgerd, J.P., Horwitz, B.H., Bronson, R., Beg, A.A., Scott, M., Doerschuk, C.M., Hynes, R.O., and Baltimore, D. 2001. Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-κB in leukocyte recruitment. J. Immunol. 167: 1592-1600.
3. Bain, J., McLauchlan, H., Elliott, M., and Cohen, P. 2003. The specificities of protein kinase inhibitors: An update. Biochem. J. 371: 199-204.
4. Beg, A.A., Sha, W.C., Bronson, R.T., Ghosh, S., and Baltimore, D. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376: 167-170.
5. Bennett, B.L., Sasaki, D.T., Murray, B.W., O'Leary, E.C., Sakata, S.T., Xu, W., Leisten, J.C., Motiwala, A., Pierce, S., Satoh, Y., et al. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. 98: 13681-13686.
6. Choate, K.A., Medalie, D.A., Morgan, J.R., and Khavari, P.A. 1996. Corrective gene transfer in the human skin disorder lamellar ichthyosis. Nat. Med. 2: 1263-1267.
7. Dajee, M., Lazarov, M., Zhang, J.Y., Cai, T., Green, C.L., Russell, A.J., Marinkovich, M.P., Tao, S., Lin, Q., Kubo, Y., et al. 2003. NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421: 639-643.
8. Derijard, B., Hibi, M., Wu, I.H., Barrett, T., Su, B., Deng, T., Karin, M., and Davis, R.J. 1994. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76: 1025-1037.
9. De Smaele, E., Zazzeroni, F., Papa, S., Nguyen, D.U., Jin, R., Jones, J., Cong, R., and Franzoso, G. 2001. Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling. Nature 414: 308-313.
10. Dixit, V. and Mak, T.W. 2002. NF-κB signaling. Many roads lead to madrid. Cell 111: 615-619.
11. Franzoso, G., Carlson, L., Poljak, L., Shores, E.W., Epstein, S., Leonardi, A., Grinberg, A., Tran, T., Scharton-Kerstcn, T., Anver, M., et al. 1998. Mice deficient in nuclear factor (NF)-κ B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J. Exp. Med. 187: 147-159.
12. Fuchs, E. and Raghavan, S. 2002. Getting under the skin of epidermal morphogenesis. Nat. Rev. Genet. 3: 199-209.
13. Ghosh, S. and Karin, M. 2002. Missing pieces in the NF-κB puzzle. Cell 109 Suppl: S81-S96.
14. Hayakawa, J., Depatie, C., Ohmichi, M., and Mercola, D. 2003. The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair. J. Biol. Chem. 278: 20582-20592.
15. Hinata, K., Gervin, A.M., Zhang, J.Y., and Khavari, P.A. 2003. Divergent gene regulation and growth effects by NF-κB in epithelial and mesenchymal cells of human skin. Oncogene 22: 1955-1964.
16. Hu, Y., Baud, V., Delhase, M., Zhang, P., Deerinck, T., Ellisman, M., Johnson, R., and Karin, M. 1999. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase. Science 284: 316-320.
17. Hu, Y., Baud, V., Oga, T., Kim, K.I., Yoshida, K., and Karin, M. 2001. IKKα controls formation of the epidermis independently of NF-κB. Nature 410: 710-714.
18. Johnson, G.L. and Lapadat, R. 2002. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912.
19. Kock, A., Schwarz, T., Kirnbauer, R., Urbanski, A., Perry, P., Ansel, J.C., and Luger, T.A. 1990. Human keratinocytes are a source for tumor necrosis factor α: Evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J. Exp. Med. 172: 1609-1614.
20. Kontgen, F., Grumont, R.J., Strasser, A., Metcalf, D., Li, R., Tarlinton, D., and Gerondakis, S. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes & Dev. 9: 1965-1977.
21. Li, X., Massa, P.E., Hanidu, A., Peet, G.W., Aro, P., Savitt, A., Mische, S., Li, J., and Marcu, K.B. 2002. IKKα, IKKβ, and NEMO/IKKγ, are each required for the NF-κ B-mediated inflammatory response program. J. Biol. Chem. 277: 45129-45140.
22. Liu, Z.G., Hsu, H., Goeddel, D.V., and Karin, M. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87: 565-576.
23. Makris, C., Godfrey, V.L., Krahn-Senftleben, G., Takahashi, T., Roberts, J.L., Schwarz, T., Feng, L., Johnson, R.S., and Karin, M. 2000. Female mice heterozygous for IKK γ/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol. Cell 5: 969-979.
24. Oro, A.E., Higgins, K.M., Hu, Z., Bonifas, J.M., Epstein, E.H., and Scott, M.P. 1997. Basal cell carcinomas in mice overexpressing some hedgehog. Science 276: 817-821.
25. Pasparakis, M., Courtois, G., Hafner, M., Schmidt-Supprian, M., Nenci, A., Toksoy, A., Krampert, M., Goebeler, M., Gillitzer, R., Israel, A., et al. 2002. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature 417: 861-866.
26. Reuther-Madrid, J.Y., Kashatus, D., Chen, S., Li, X., Westwick, J., Davis, R.J., Earp, H.S., Wang, C.Y., and Baldwin Jr., A.S. 2002. The p65/RelA subunit of NF-κB suppresses the sustained, antiapoptotic activity of Jun kinase induced by tumor necrosis factor. Mol. Cell. Biol. 22: 8175-8183.
27. Robbins, P.B., Lin, Q., Goodnough, J.B., Tian, H., Chen, X., and Khavari, P.A. 2001. In vivo restoration of laminin 5 β 3 expression and function in junctional epidermolysis bullosa. Proc. Natl. Acad. Sci. 98: 5193-5198.
28. Rosenfeld, M.E., Prichard, L., Shiojiri, N., and Fausto, N. 2000. Prevention of hepatic apoptosis and embryonic lethality in RelA/TNFR-1 double knockout mice. Am. J. Pathol. 156: 997-1007.
29. Schmidt-Supprian, M., Bloch, W., Courtois, G., Addicks, K., Israel, A., Rajewsky, K., and Pasparakis, M. 2000. NEMO/IKK γ-deficient mice model incontinentia pigmenti. Mol. Cell 5: 981-992.
30. Seitz, C.S., Lin, Q., Deng, H., and Khavari, P.A. 1998. Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB. Proc. Natl. Acad. Sci. 95: 2307-2312.
31. Seitz, C.S., Deng, H., Hinata, K., Lin, Q., and Khavari, P.A. 2000a. Nuclear factor κB subunits induce epithelial cell growth arrest. Cancer Res. 60: 4085-4092.
32. Seitz, C.S., Freiberg, R.A., Hinata, K., and Khavari, P.A. 2000b. NF-κB determines localization and features of cell death in epidermis. J. Clin. Invest. 105: 253-260.
33. Sha, W.C., Liou, H.C., Tuomanen, E.I., and Baltimore, D. 1995. Targeted disruption of the p50 subunit of NF-κ B leads to multifocal defects in immune responses. Cell 80: 321-330.
34. Takeda, K., Takeuchi, O., Tsujimura, T., Itami, S., Adachi, O., Kawai, T., Sanjo, H., Yoshikawa, K., Terada, N., and Akira, S. 1999. Limb and skin abnormalities in mice lacking IKKα. Science 284: 313-316.
35. Tang, G., Minemoto, Y., Dibling, B., Purcell, N.H., Li, Z., Karin, M., and Lin, A. 2001. Inhibition of JNK activation through NF-κB target genes. Nature 414: 313-317.
36. van Hogerlinden, M., Rozell, B.L., Ahrlund-Richter, L., and Toftgard, R. 1999. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-κB signaling. Cancer Res. 59: 3299-3303.
37. Weih, F., Carrasco, D., Durham, S.K., Barton, D.S., Rizzo, C.A., Ryseck, R.P., Lira, S.A., and Bravo, R. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κ B/Rel family. Cell 80: 331-340.